NCT00272688已完成4 期
Continuous Delivery of Levodopa/Carbidopa (Duodopa) in Patients With Advanced Idiopathic Parkinsons Disease - a Health Economic Evaluation
University Hospital, Akershus4 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2006年1月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
- 试验地点
- 4
- 主要终点
- Marginal cost per QALY of replacing conventional treatment with intraduodenal levodopa
研究概览
简要总结
An open, observational health economic study to estimate marginal cost and health consequences of replacing conventional Parkinsons disease therapy with intraduodenal levodopa administered continuously
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Clinical diagnosis of of idiopathic Parkinsons disease
- •Motor fluctuations despite optimised per oral treatment
排除标准
- •Severe dementia, confusion, psychosis or depression
- •Patients with contraindications against levodopa treatment
结局指标
主要结局
Marginal cost per QALY of replacing conventional treatment with intraduodenal levodopa
时间窗: one year
Quality of life at three, six, nine and twelve months(Assessed by Nottingham Health Profile (NHP), Parkinson Disease Questionnaire (PDQ39), 15D Quality of life)
次要结局
- Parkinson related function at three, six, nine and twelve months(UPDRS, Hoehn and Yahr scores, Schwab and England)
研究者
Christofer Lundqvist
Principal investigator
University Hospital, Akershus
研究点 (4)
Loading locations...
相似试验
已完成
不适用
Observational Study to Evaluate PAD Treatment Clinical and Economic OutcomesPeripheral Arterial Occlusive DiseaseNCT01855412Abbott Medical Devices1,204
撤回
4 期
Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing OffParkinson's DiseaseNCT00601978Novartis Pharmaceuticals
终止
4 期
Economic Impact of Dropless Therapy Versus Usual Care for Cataract Surgery: A Real-World Study.Cataract SurgeryNCT03640650PeriPharm80
已完成
3 期
A Multicenter, Open-label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects With Stable Parkinson's DiseaseParkinson's DiseaseNCT00139867UCB Pharma
招募中
4 期
Basic and Clinical Studies of Levodopa/Carbidopa/Entacapone in the Treatment of Early Parkinson's DiseaseParkinson DiseaseNCT06236230Second Affiliated Hospital of Soochow University60